Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy

Journal of the American Society of Nephrology

Volumn 8, Issue 7, 1997, Pages 1140-1146

  Burns, Godfrey C ^a,b,c   Paul, Subir K ^a   Toth, Ilona R ^a,b   Sivak, Steven L ^a,b  

^a ST VINCENT S HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOSINOPRIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEINURIA;

EID: 0030832061     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Rao TK: Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 40[Suppl 35]: S13-S18, 1991
2. Carbone L, D'Agati N, Cheng JT, Appel GB: The course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87: 389-395, 1989
3. Bourgoignie JJ, Menses R, Ortiz C, Jaffe D, Pardo V: The clinical spectrum of renal disease associated with immunodeficiency virus. Am J Kidney Dis 12: 131-137, 1988
4. Bourgoignie JJ, Ortiz-Interian C, Green DF, Jaffe D, Roth D, Pardo V: The epidemiology of human immunodeficiency virus-associated nephropathy. In: Nephrology, edited by Hatan M, Tokyo, Springer Verlag, 1990, pp 484-492
5. Humphreys MH: Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 48: 311-320, 1995
6. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456-1462, 1993
7. Marre M, LeBlanc H, Suarez L, Guyenne Y, Menard J, Passa P: Converting enzyme and kidney function in normotensive diabetic patients with persistent proteinuria. Br Med J 294: 1448-1452, 1987
8. Ihle MB, Whiteworth JA, Shahinfar S, Cnaan A, Kinkaid-Smith P, Becker GJ: Am J Kidney Dis 27: 489-495, 1996
9. Toto R, Mitchell H, Fletcher S et al: Long-acting converting enzyme inhibitors (ACEIs) lower blood pressure equally in blacks and whites with kidney disease and hypertension. Am J Hypertens 50A: 21-22, 1993
10. Taguma Y, KitamotoY, Futaki G, Ueda H, Monma H, Ishizaki M, Takahashi H, Sekino H, Sasaki Y: Effect of captopril on heavy proteinuria in azotemic diabetics. N Engl J Med 313: 1617-1620, 1985
11. Bjorck S, Mulec H, Johnsonsen S, Norden G, Aurell MN: Renal protective effects of enalapril in diabetic nephropathy. Br Med J 304: 339-343, 1992
12. Anderson S, Meyer T, Rennke H, Brenner B: Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76: 512-619, 1985
13. Zatz R, Meyer T, Rennke H, Brenner B: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 82: 5963-5967, 1985
14. Zatz R, Dunn R, Meyer T, Anderson S, Rennke H, Brenner B: Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. J Clin Invest 77: 1926-1930, 1986
15. Raij L, Keane WF: Glomerular mesangium: Its function and relationship to angiotensin II. Am J Med 79[Suppl 3C]: 24-30, 1985
16. Fogo A, Yoshida Y, Glick AD, Homma T, Ichikawa I: Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis. J Clin Invest 32: 322-330, 1989
17. Hommel E, Parving H, Mathiesen E, Edsberg B, Neilson M, Giese J: Effect of captopril on kidney function insulin-dependent diabetic patients with nephropathy. Br Med J 293: 467-470, 1986
18. Remuzzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 38: 384-394, 1990
19. Remuzzi A, Perticucci A, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 39: 1267-1273, 1991
20. Dzau VJ: Cell biology and genetics of angiotensin in cardiovascular disease. J Hypertens 12[Suppl 4]: S3-S10, 1994
21. Kagami S, Border W, Miller D, Nobel N: Angiotensin II stimulates extracellular matrix synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93: 2431-2437, 1994
22. Klahr S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 18: 689-699, 1991
23. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S: Enalapril reduces collagen type I and expansion of the interstitium in the obstructed rat kidney. Kidney Int 45: 1637-1647, 1994
24. Pimentel L, Sundell C, Wang S, Kopp J, Montero A, Martinez-Maldonado M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48: 1233-1246, 1995
25. Ishdoya S, Morrissey J, McCraken R, Reyes A, Klahr S: Angiotensin receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by ureteral obstruction. Kidney Int 47: 1285-1294, 1995
26. Ruiz-Ortega M, Gonzalez S, Seron D, Condon E, Bustos C, Largo L, Gonzalex E, Ortiz A, Egido J: Ace inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis. Kidney Int 48: 1778-1791, 1995
27. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 228: 363-378, 1986
28. Velosa JA, Holley KE, Torres VE, Offord KP: Significance of proteinuria on the outcome of function in patients with focal glomerulosclerosis. Mayo Clin Proc 9: 568-577, 1983
29. Cameron JS: Clinicopathologic correlations in glomerular disease. In: Kidney Disease- Present Status, edited by Sommer W, Baltimore, Williams & Wilkins, 1979, p 76
30. Burns GC, Matute R, Onyema D, Davis I, Toth L: Response to inhibition of angiotensin- converting enzyme in human immunodeficiency virus associated nephropathy: A case report. Am J Kidney Dis 23: 441-443, 1994
31. Anderson S, Rennke H, Brenner B: Therapeutic advantages of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 11: 1993-2000, 1986
32. Falk RJ, Scheinman J, Phillips G, Orringer E, Jonhson A, Jennette JC: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin- converting enzyme. N Engl J Med 326: 910-915, 1992
33. Gansevoort RT, De Zeeuw D, Jong PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int 45: 861-867, 1994
34. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC: Control of glomerular filtration rate by the renin-angiotensin system. Am J Physiol 233: F366-F372, 1977
35. Ichikawi I, Harris RC: Angiotensin actions in the kidney: Renewed insight into the old hormone. Kidney Int 40: 583-596, 1991
36. Langs C, Gallo GR, Schact RG, Sidhu G, Baldwin DS: Rapid renal failure in acquired immunodeficiency syndrome-associated glomerulosclerosis. Arch Int Med 150: 287-292, 1992
37. Wolf G, Neilson G: Angiotensin II as a renal growth factor. J Am Soc Nephrol 3: 1531-1540, 1993
38. Owens EK: Control of hypertrophic versus growth of vascular smooth muscle cells. Am J Physiol 257: H1755-H1765, 1989
39. Baker KM, Aceto JF: Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 259: H610-H618, 1990
40. Jin M, Wilhelm MJ. Lang RE, Unger T, Lidpainter K, Ganten D: Endogenous tissue renin-angiotensin systems from molecular biology to therapy. Am J Med 84[Suppl 3A]: 28-36, 1988
41. Fogo A, Yoshida Y, Yared A, Ichikawa I: Importance of angiogenic angiotensin II in the glomerular growth of maturing kidneys. Kidney Int 38: 1068-1074, 1990
42. Milan MA, Carvello P, Izumi S, Zeme S, Catt KJ, Aguilera G: Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244: 13440-13442, 1989
43. Everett AD, Scott J, Wilfong N, Marino B, Rosenkranz RP, Inagami T, Gomez RA: Renin and angiotensinogen expression during the evolution of diabetes mellitus. Hypertension 19: 70-78, 1992
44. Gibbons GH, Pratt RE, Dzau VJ: Vascular smooth muscle cell hypertrophy vs hyperplasia: Autocrine transforming growth factor-β expression determines growth response to Ang II in rat glomerular mesangial cells. J Clin Invest 90: 456-461, 1992
45. Rappaport J, Kopp JB, Klotman PE: Host virus interactions and the molecular regulation of HIV-associated nephropathy. Kidney Int 46: 16-27, 1994